Literature DB >> 15963794

Development of methods for the detection and quantification of 7alpha-dehydroxylating clostridia, Desulfovibrio vulgaris, Methanobrevibacter smithii, and Lactobacillus plantarum in human feces.

Jason M Ridlon1, Sean E McGarr, Phillip B Hylemon.   

Abstract

BACKGROUND: Mounting evidence suggests a relationship between bacterial metabolism of certain dietary and endogenous factors and the development of colorectal cancer. Deoxycholic acid (DCA) is a well studied co-carcinogen and bio-transformation product of 7alpha-dehydroxylating Clostridia. H2S is a cytotoxic metabolite produced primarily by sulfate-reducing bacteria (SRB). The production of methane indicates low levels of active SRB. Lactic acid bacteria (LAB) have received attention recently due to their putative anti-tumor properties.
METHOD: Human stool was spiked with pure cultures of bacteria and diluted in several enriched media. Each dilution titer was analyzed for the presence of the organism by PCR and biochemical assays. Duplicate stool aliquots were stored under various conditions for a 1 month period at -20 degrees C to test viability and detection.
RESULTS: Growth and enumeration of each spiked organism was confirmed by PCR and biochemical assays. The combination of bead beating and chemical lysis steps produced the greatest DNA yields. PCR assays detected as low as 75 fg target DNA. The ability to detect Methanobrevibacter smithii, and Desulfovibrio vulgaris by either PCR or biochemical assay declined significantly after storage at -20 degrees C for 1 month.
CONCLUSIONS: Accurate detection and quantification of each bacterium using the described methods resulted when stool was processed immediately after collection. Storage of some members of the gut flora results in decrease in or loss of viability.

Entities:  

Mesh:

Year:  2005        PMID: 15963794     DOI: 10.1016/j.cccn.2005.02.004

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Linkage of gut microbiome with cognition in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Jason M Ridlon; Phillip B Hylemon; Leroy R Thacker; Douglas M Heuman; Sean Smith; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-22       Impact factor: 4.052

2.  Clostridium scindens ATCC 35704: Integration of Nutritional Requirements, the Complete Genome Sequence, and Global Transcriptional Responses to Bile Acids.

Authors:  Saravanan Devendran; Rachana Shrestha; João M P Alves; Patricia G Wolf; Lindsey Ly; Alvaro G Hernandez; Celia Méndez-García; Ashley Inboden; J'nai Wiley; Oindrila Paul; Avery Allen; Emily Springer; Chris L Wright; Christopher J Fields; Steven L Daniel; Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

3.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Authors:  Jasmohan S Bajaj; Phillip B Hylemon; Jason M Ridlon; Douglas M Heuman; Kalyani Daita; Melanie B White; Pamela Monteith; Nicole A Noble; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-19       Impact factor: 4.052

4.  Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  Anaerobe       Date:  2009-05-21       Impact factor: 3.331

5.  Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens.

Authors:  Jason M Ridlon; Shigeo Ikegawa; João M P Alves; Biao Zhou; Akiko Kobayashi; Takashi Iida; Kuniko Mitamura; Genzoh Tanabe; Myrna Serrano; Ainee De Guzman; Patsy Cooper; Gregory A Buck; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2013-06-15       Impact factor: 5.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.